D.J. St. Germain’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
1,756
+2
+0.1% +$2.04K 0.08% 135
2026
Q1
$1.61M Sell
1,754
-2
-0.1% -$2.03K 0.06% 146
2025
Q4
$1.89M Buy
1,756
+57
+3% +$54.5K 0.07% 138
2025
Q3
$1.3M Sell
1,699
-147
-8% -$109K 0.05% 150
2025
Q2
$1.44M Buy
1,846
+179
+11% +$139K 0.06% 148
2025
Q1
$1.38M Buy
1,667
+55
+3% +$45.8K 0.06% 144
2024
Q4
$1.24M Sell
1,612
-1,029
-39% -$852K 0.06% 161
2024
Q3
$2.34M Sell
2,641
-52
-2% -$46.8K 0.11% 125
2024
Q2
$2.44M Buy
2,693
+1,407
+109% +$1.13M 0.12% 115
2024
Q1
$1M Sell
1,286
-26
-2% -$18.5K 0.05% 163
2023
Q4
$765K Buy
1,312
+66
+5% +$38.5K 0.04% 171
2023
Q3
$669K Sell
1,246
-456
-27% -$235K 0.04% 169
2023
Q2
$798K Buy
+1,702
New +$714K 0.04% 160
2022
Q4
$339K Buy
2,728
+866
+47% +$307K 0.11% 83
2022
Q3
$604K Hold
1,862
0.04% 142
2022
Q2
$604K Hold
1,862
0.04% 142
2022
Q1
$533K Hold
1,862
0.03% 158
2021
Q4
$514K Buy
1,862
+275
+17% +$69.7K 0.03% 170
2021
Q3
$367K Buy
1,587
+132
+9% +$32.6K 0.02% 186
2021
Q2
$334K Buy
1,455
+51
+4% +$10.2K 0.02% 197
2021
Q1
$262K Sell
1,404
-12
-0.8% -$2.35K 0.02% 207
2020
Q4
$239K Hold
1,416
0.02% 210
2020
Q3
$210K Hold
1,416
0.02% 208
2020
Q2
$232K Buy
+1,416
New +$217K 0.02% 200
2016
Q4
Sell
-8,123
Closed -$652K 141
2016
Q3
$652K Buy
8,123
+342
+4% +$27.4K 0.09% 87
2016
Q2
$613K Buy
7,781
+521
+7% +$39.2K 0.09% 96
2016
Q1
$523K Buy
7,260
+1,466
+25% +$111K 0.07% 97
2015
Q4
$488K Buy
+5,794
New +$481K 0.07% 92

Other funds holding LLY

D.J. St. Germain's LLY Position: Q2 2026 in Review

D.J. St. Germain increased its Eli Lilly (LLY) stake by 0.11% in Q2 2026, buying an estimated $2.04K and bringing the position to 1,756 shares worth $2.11M. The position accounts for 0.08% of the portfolio, ranked #135.

D.J. St. Germain first reported a position in LLY in Q4 2015 and has held it in 28 quarters since. The position peaked at $2.44M in Q2 2024. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • D.J. St. Germain held 1,756 shares of Eli Lilly worth $2.11M as of Q2 2026.
  • D.J. St. Germain bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.08% of D.J. St. Germain's portfolio in Q2 2026, its #135 holding.
  • D.J. St. Germain first reported a position in Eli Lilly in Q4 2015 and has held it in 28 quarters since.
  • D.J. St. Germain's Eli Lilly position peaked at $2.44M in Q2 2024.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.